| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | striatum development | 1.77e-05 | 22 | 48 | 3 | GO:0021756 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the N-end rule pathway | 3.17e-05 | 4 | 48 | 2 | GO:0071596 | |
| GeneOntologyBiologicalProcess | subpallium development | 3.72e-05 | 28 | 48 | 3 | GO:0021544 | |
| GeneOntologyCellularComponent | BBSome | 1.43e-04 | 8 | 48 | 2 | GO:0034464 | |
| Domain | Laminin_EGF | 9.24e-05 | 35 | 47 | 3 | PF00053 | |
| Domain | Laminin_EGF | 1.18e-04 | 38 | 47 | 3 | IPR002049 | |
| Domain | zf-UBR | 1.29e-04 | 7 | 47 | 2 | PF02207 | |
| Domain | Znf_UBR | 1.29e-04 | 7 | 47 | 2 | IPR003126 | |
| Domain | ZnF_UBR1 | 1.29e-04 | 7 | 47 | 2 | SM00396 | |
| Domain | ZF_UBR | 1.29e-04 | 7 | 47 | 2 | PS51157 | |
| Domain | - | 1.94e-03 | 26 | 47 | 2 | 3.60.10.10 | |
| Domain | Exo_endo_phos | 1.94e-03 | 26 | 47 | 2 | PF03372 | |
| Domain | Endo/exonuclease/phosphatase | 2.09e-03 | 27 | 47 | 2 | IPR005135 | |
| Domain | EGF_Lam | 3.50e-03 | 35 | 47 | 2 | SM00180 | |
| Domain | EGF_1 | 3.82e-03 | 255 | 47 | 4 | PS00022 | |
| Domain | EGF_2 | 4.38e-03 | 265 | 47 | 4 | PS01186 | |
| Domain | Glycoside_hydrolase_SF | 7.87e-03 | 53 | 47 | 2 | IPR017853 | |
| Domain | Quinoprotein_ADH-like_supfam | 7.87e-03 | 53 | 47 | 2 | IPR011047 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 15322545 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 17959775 | ||
| Pubmed | The BBSome assembly is spatially controlled by BBS1 and BBS4 in human cells. | 1.94e-06 | 2 | 49 | 2 | 32759308 | |
| Pubmed | Loss of Bardet-Biedl syndrome proteins causes synaptic aberrations in principal neurons. | 5.83e-06 | 3 | 49 | 2 | 31479441 | |
| Pubmed | Ciliopathy proteins regulate paracrine signaling by modulating proteasomal degradation of mediators. | 5.83e-06 | 3 | 49 | 2 | 24691443 | |
| Pubmed | Basal body proteins regulate Notch signaling through endosomal trafficking. | 5.83e-06 | 3 | 49 | 2 | 24681783 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 25504142 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 18032602 | ||
| Pubmed | Reversal of ciliary mechanisms of disassembly rescues olfactory dysfunction in ciliopathies. | 1.16e-05 | 4 | 49 | 2 | 35771640 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 18299575 | ||
| Pubmed | A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons. | 1.16e-05 | 4 | 49 | 2 | 16055722 | |
| Pubmed | Evaluation of complex inheritance involving the most common Bardet-Biedl syndrome locus (BBS1). | 1.16e-05 | 4 | 49 | 2 | 12524598 | |
| Pubmed | The substrate recognition domains of the N-end rule pathway. | 1.16e-05 | 4 | 49 | 2 | 19008229 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 30665891 | ||
| Pubmed | Regulation of Insulin Receptor Trafficking by Bardet Biedl Syndrome Proteins. | 1.16e-05 | 4 | 49 | 2 | 26103456 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 32433491 | ||
| Pubmed | Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling. | 1.94e-05 | 5 | 49 | 2 | 19150989 | |
| Pubmed | Disruption of Bardet-Biedl syndrome ciliary proteins perturbs planar cell polarity in vertebrates. | 1.94e-05 | 5 | 49 | 2 | 16170314 | |
| Pubmed | BBS proteins interact genetically with the IFT pathway to influence SHH-related phenotypes. | 2.91e-05 | 6 | 49 | 2 | 22228099 | |
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 24939912 | ||
| Pubmed | BBS mutations modify phenotypic expression of CEP290-related ciliopathies. | 4.07e-05 | 7 | 49 | 2 | 23943788 | |
| Pubmed | Protein interaction perturbation profiling at amino-acid resolution. | 4.07e-05 | 7 | 49 | 2 | 29039417 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | 5.20e-05 | 1242 | 49 | 9 | 30973865 | |
| Pubmed | Dissection of epistasis in oligogenic Bardet-Biedl syndrome. | 5.42e-05 | 8 | 49 | 2 | 16327777 | |
| Pubmed | Genome-wide association study of the rate of cognitive decline in Alzheimer's disease. | 5.86e-05 | 53 | 49 | 3 | 23535033 | |
| Pubmed | Direct role of Bardet-Biedl syndrome proteins in transcriptional regulation. | 6.96e-05 | 9 | 49 | 2 | 22302990 | |
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 18762586 | ||
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 20603001 | ||
| Pubmed | Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation. | 6.96e-05 | 9 | 49 | 2 | 17855541 | |
| Pubmed | Ubiquitylation of BBSome is required for ciliary assembly and signaling. | 6.96e-05 | 9 | 49 | 2 | 36744302 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 7.33e-05 | 736 | 49 | 7 | 29676528 | |
| Pubmed | A novel protein LZTFL1 regulates ciliary trafficking of the BBSome and Smoothened. | 8.69e-05 | 10 | 49 | 2 | 22072986 | |
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 17574030 | ||
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 27979967 | ||
| Pubmed | Temporal expression pattern of Bardet-Biedl syndrome genes in adipogenesis. | 8.69e-05 | 10 | 49 | 2 | 17379567 | |
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 22139371 | ||
| Pubmed | Identification of a Nuclear Exosome Decay Pathway for Processed Transcripts. | 8.69e-05 | 10 | 49 | 2 | 27871484 | |
| Pubmed | A BBSome subunit links ciliogenesis, microtubule stability, and acetylation. | 8.69e-05 | 10 | 49 | 2 | 19081074 | |
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 24550735 | ||
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 27217161 | ||
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 25552655 | ||
| Pubmed | 1.26e-04 | 1084 | 49 | 8 | 11544199 | ||
| Pubmed | HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1. | 1.27e-04 | 12 | 49 | 2 | 17360488 | |
| Pubmed | TNF-α sculpts a maturation process in vivo by pruning tolerogenic dendritic cells. | 1.50e-04 | 13 | 49 | 2 | 35417681 | |
| Pubmed | 1.50e-04 | 13 | 49 | 2 | 22500027 | ||
| Pubmed | BBS6, BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and mediate BBSome assembly. | 2.02e-04 | 15 | 49 | 2 | 20080638 | |
| Pubmed | 2.02e-04 | 15 | 49 | 2 | 22922713 | ||
| Pubmed | Network-driven discovery yields new insight into Shox2-dependent cardiac rhythm control. | 2.61e-04 | 17 | 49 | 2 | 33706013 | |
| Pubmed | FIP200 controls the TBK1 activation threshold at SQSTM1/p62-positive condensates. | 2.78e-04 | 223 | 49 | 4 | 34226595 | |
| Pubmed | ¹H NMR metabolic profiling of plasma reveals additional phenotypes in knockout mouse models. | 3.64e-04 | 20 | 49 | 2 | 25849460 | |
| Pubmed | Novel interaction partners of Bardet-Biedl syndrome proteins. | 4.01e-04 | 21 | 49 | 2 | 18000879 | |
| Pubmed | 4.54e-04 | 457 | 49 | 5 | 22190034 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 6.66e-04 | 759 | 49 | 6 | 35915203 | |
| Pubmed | 6.67e-04 | 27 | 49 | 2 | 20301537 | ||
| Pubmed | 7.78e-04 | 515 | 49 | 5 | 31617661 | ||
| Pubmed | 8.25e-04 | 30 | 49 | 2 | 19077438 | ||
| Pubmed | 8.41e-04 | 1440 | 49 | 8 | 30833792 | ||
| Pubmed | 8.49e-04 | 1442 | 49 | 8 | 35575683 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 9.16e-04 | 807 | 49 | 6 | 30575818 | |
| Pubmed | 9.98e-04 | 33 | 49 | 2 | 25582440 | ||
| Pubmed | 1.04e-03 | 1487 | 49 | 8 | 33957083 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.33e-03 | 153 | 49 | 3 | 26365490 | |
| Cytoband | 3q13.2 | 5.09e-04 | 31 | 49 | 2 | 3q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q13 | 1.72e-03 | 221 | 49 | 3 | chr3q13 | |
| Cytoband | 21q22.11 | 2.03e-03 | 62 | 49 | 2 | 21q22.11 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 3.84e-05 | 7 | 25 | 2 | 785 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 5.11e-05 | 8 | 25 | 2 | 1122 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 3.79e-04 | 21 | 25 | 2 | 980 | |
| GeneFamily | Ankyrin repeat domain containing | 4.38e-03 | 242 | 25 | 3 | 403 | |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP | 3.57e-05 | 200 | 49 | 5 | M6004 | |
| Coexpression | GSE557_WT_VS_I_AB_KO_DC_UP | 3.57e-05 | 200 | 49 | 5 | M6009 | |
| Coexpression | GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP | 3.57e-05 | 200 | 49 | 5 | M3035 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.44e-06 | 176 | 49 | 5 | ad05dd934f4ac2e656b3455de091f4c8772de6c8 | |
| ToppCell | Healthy-B_intermediate|Healthy / disease group, cell group and cell class | 2.31e-06 | 194 | 49 | 5 | aabee48bf689367edae2079b4b90d253715f1097 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.60e-06 | 121 | 49 | 4 | e82c9e10b98c8d7ad828cf8ac19a2342014be2ba | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.61e-05 | 156 | 49 | 4 | d81e78bec5c8a3f3ec9e1447ebab2c5805b815eb | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-naive_B_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.88e-05 | 160 | 49 | 4 | bfbac5ed3273b4430314c6c25cdc1bf0c42b27a1 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.17e-05 | 164 | 49 | 4 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.25e-05 | 165 | 49 | 4 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_naive|bone_marrow / Manually curated celltypes from each tissue | 3.73e-05 | 171 | 49 | 4 | fcc31a9a69f96de10d1324a5a4fbfe4289bf4984 | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 4.18e-05 | 176 | 49 | 4 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.27e-05 | 177 | 49 | 4 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.27e-05 | 177 | 49 | 4 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.56e-05 | 180 | 49 | 4 | 40a12eb852373ae3d7c8d9bca376b0ae99f724b3 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.66e-05 | 181 | 49 | 4 | 57f20341c3e9f9f6ed5b6c181605ad35bae91414 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.66e-05 | 181 | 49 | 4 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.76e-05 | 182 | 49 | 4 | 63c3b63315276b66667d49fab09661ac320e7a36 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.86e-05 | 183 | 49 | 4 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.86e-05 | 183 | 49 | 4 | 01664fce6b70a02c9d39d747b6a6aabc86d57bc2 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.18e-05 | 186 | 49 | 4 | d7d884ff4184636081c350d29f797bd923c6a3b4 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B-Naive_B_cells|Liver / Manually curated celltypes from each tissue | 5.18e-05 | 186 | 49 | 4 | 23efdcedbe67f5e6c59106e052f570cd0338f1c1 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-8|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.29e-05 | 187 | 49 | 4 | c10d6a774b3e83f64e47b9ad08f5d6b0dc60d163 | |
| ToppCell | Immune-B_cell|World / Lineage, Cell type, age group and donor | 5.29e-05 | 187 | 49 | 4 | 795690c6306c366e733279491138d0cd9b469b21 | |
| ToppCell | Healthy-B_naive|World / disease group, cell group and cell class | 5.51e-05 | 189 | 49 | 4 | 1e533a43f739ff295740cf2b25479756dfb8e595 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.51e-05 | 189 | 49 | 4 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.63e-05 | 190 | 49 | 4 | a7498fe55b7810c482291db782dc5282675d246a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.63e-05 | 190 | 49 | 4 | 112706d64ee73b55dcf76f33ca064ab1fc6ce87f | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Naive_B_cells|bone_marrow / Manually curated celltypes from each tissue | 5.63e-05 | 190 | 49 | 4 | 3d45d5011305f13634013d9eeb98f235517dd54e | |
| ToppCell | Control-Lymphoid_B-B_intermediate|Control / Disease group, lineage and cell class | 5.74e-05 | 191 | 49 | 4 | 0082181dbc39c7c4fd3aa34c3ed61439548e844b | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.74e-05 | 191 | 49 | 4 | 84452125d1b5b76974e3f9126f611eff16d45c25 | |
| ToppCell | Healthy-B_naive|Healthy / disease group, cell group and cell class | 5.86e-05 | 192 | 49 | 4 | 5fddf679dcc9c0077d6bfe04c1e602863fb959eb | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B|bone_marrow / Manually curated celltypes from each tissue | 5.86e-05 | 192 | 49 | 4 | 8a284b6e499f5a3c116d5551430f00ecad4a3681 | |
| ToppCell | Healthy/Control-B_intermediate|World / Disease group and Cell class | 5.86e-05 | 192 | 49 | 4 | 2266aa695955f5d885708e6bc0d5a8827c306223 | |
| ToppCell | COVID_non-vent-Lymphocytic-B_cell-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.98e-05 | 193 | 49 | 4 | 91955c3773c9729a96e82f240f06b072367970d9 | |
| ToppCell | COVID_non-vent-Lymphocytic-B_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.98e-05 | 193 | 49 | 4 | 32d139f922cd19adc1cc1e0e9a828115be9945d6 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.10e-05 | 194 | 49 | 4 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | Control-Lymphoid_B-B_naive|Control / Disease group, lineage and cell class | 6.10e-05 | 194 | 49 | 4 | 4f9600960a287cfc020c06b4af3528d4e5797916 | |
| ToppCell | Healthy/Control-B_intermediate|Healthy/Control / Disease group and Cell class | 6.10e-05 | 194 | 49 | 4 | 8a4260eeccb4924c392798b1ffa23cdd3a4062e9 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B|bone_marrow / Manually curated celltypes from each tissue | 6.22e-05 | 195 | 49 | 4 | bcbf0305ca9337a6f3021178dbb47a7fbf1030a4 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.22e-05 | 195 | 49 | 4 | 80b973d2a23ef9b101c90e1635e68c9a3f78f65d | |
| ToppCell | Healthy-B_intermediate|World / disease group, cell group and cell class | 6.22e-05 | 195 | 49 | 4 | 9de79e0bdd9063ae65e5edb89cc3fe6f9a8173bc | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.35e-05 | 196 | 49 | 4 | fcbfd8c4771d99a45fc53e482ef98edabe8ef591 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.35e-05 | 196 | 49 | 4 | f45cb8f714ae7ac800768df65f299b98a2d42962 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.35e-05 | 196 | 49 | 4 | d7e6c89cb49933b4a86d26d15f6772f2481d37ef | |
| ToppCell | control-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.47e-05 | 197 | 49 | 4 | 559650fb53f18ecae4cfaa8221e978ae3fb63e06 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.47e-05 | 197 | 49 | 4 | da61afba697ec49ca86e062d35a825280da558ac | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.60e-05 | 198 | 49 | 4 | 9ab0db78394e730f6866b2db80047149024ad5f6 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.60e-05 | 198 | 49 | 4 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.60e-05 | 198 | 49 | 4 | e47d0e2c6353315c85d7007742bb16b0f05795ed | |
| ToppCell | Control-Control-Lymphocyte-B-B_intermediate|Control / Disease, condition lineage and cell class | 6.73e-05 | 199 | 49 | 4 | ee6f07eec7edfe41d2f7fcb0b509ce00e99a6a95 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-B_naive|COVID-19_Mild / Disease, condition lineage and cell class | 6.86e-05 | 200 | 49 | 4 | e6a43eff47195e1d39530ad49ad908fc06a8b038 | |
| ToppCell | Control-Control-Lymphocyte-B-B_naive|Control / Disease, condition lineage and cell class | 6.86e-05 | 200 | 49 | 4 | 15e4b9956b9a0c2e6927a802e86e1cb4bb18b89a | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B|Influenza_Severe / Disease, condition lineage and cell class | 6.86e-05 | 200 | 49 | 4 | bf238a0a074d6c5cba8cb73d3b715ee701a612b6 | |
| ToppCell | LA-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.77e-04 | 128 | 49 | 3 | 071becbe97598c2b65580b0989eb664d6fd6c85a | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.03e-04 | 131 | 49 | 3 | a3a086ce6e69707ca6a042f3b15c130f81909acb | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_E|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.40e-04 | 135 | 49 | 3 | 35928195cf34f055b353562c96f451aef2344d64 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.69e-04 | 138 | 49 | 3 | 76be06136c83c167cedece7515228ed4d29dd1f0 | |
| ToppCell | Healthy-B_cell|World / disease group, cell group and cell class | 5.53e-04 | 146 | 49 | 3 | 588359d3df6ad7090b7fa6c7f8d29cc1717e7f4f | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.87e-04 | 149 | 49 | 3 | 2a7f71da51c85e04de2123164914122480e60d66 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.10e-04 | 151 | 49 | 3 | 0f8f07e44c6edaf09574930b416fdce14d67095a | |
| ToppCell | Dendritic_Cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 6.10e-04 | 151 | 49 | 3 | e089bf197ed60e7243160521d4390d4b40a3832b | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 6.21e-04 | 152 | 49 | 3 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | Healthy-B_cell|Healthy / disease group, cell group and cell class | 6.33e-04 | 153 | 49 | 3 | 7f82cd61b3f1ebaee3e4bbf68ba858a67c2065e7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.83e-04 | 157 | 49 | 3 | 29622bac6b16bb39cec4319bf4c4f92d33345e8a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 6.83e-04 | 157 | 49 | 3 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.95e-04 | 158 | 49 | 3 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-04 | 158 | 49 | 3 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-04 | 158 | 49 | 3 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 7.08e-04 | 159 | 49 | 3 | d3202ddc291b8686dbe67690df13c7daffec2199 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.08e-04 | 159 | 49 | 3 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.21e-04 | 160 | 49 | 3 | 174a4ab27114efcc63be36929b80680be3c35c9b | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.21e-04 | 160 | 49 | 3 | 5cc1b75e3c20d83112b3aa2f3c749a6c73910a2d | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.34e-04 | 161 | 49 | 3 | 98be0cf8228496b31f7f3e0efd8787e95eb626d1 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.34e-04 | 161 | 49 | 3 | 7af3b0d4fc7967f6b3e2d255d23fd8b1fd01a7af | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.48e-04 | 162 | 49 | 3 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.48e-04 | 162 | 49 | 3 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.48e-04 | 162 | 49 | 3 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 162 | 49 | 3 | e81dec1db8e5a808d96e58410c91961e5d065c94 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.48e-04 | 162 | 49 | 3 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-13|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.48e-04 | 162 | 49 | 3 | 28b3a6ae5519a267eefb70436d3190a387d027b9 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 162 | 49 | 3 | d19b469f64c9064cfb82dadb6c8135e28949a02a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.48e-04 | 162 | 49 | 3 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 162 | 49 | 3 | 10c2aa047f33f48e4abe676236bbdb593079dd1d | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-ABC_aged-B_naive|bone_marrow / Manually curated celltypes from each tissue | 7.48e-04 | 162 | 49 | 3 | 44832055b11a789e320c802aadb345e065defc8f | |
| ToppCell | metastatic_Brain-B_lymphocytes-Undetermined|metastatic_Brain / Location, Cell class and cell subclass | 7.61e-04 | 163 | 49 | 3 | 4eac7fd8acdb7f09ce739335f22a879f9b8febfb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.61e-04 | 163 | 49 | 3 | 4be3158f2a0ab460cfea8080a7370922910b5da9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-04 | 164 | 49 | 3 | 43045879505774ac0d9b7f760557955564f06d00 | |
| ToppCell | Basal_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 7.75e-04 | 164 | 49 | 3 | b15a26130a1ea1b370b6e3be21f02a0d6aaf6b3c | |
| ToppCell | 10x5'-blood-Lymphocytic_B-ABC_aged-B_memory|blood / Manually curated celltypes from each tissue | 7.75e-04 | 164 | 49 | 3 | 0424b23fc540580e7c15c50a7a03dff7c25014fa | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 7.88e-04 | 165 | 49 | 3 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_Tfh|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 8.02e-04 | 166 | 49 | 3 | c73fce59256ad501864f44f76cfae2fc33b3777e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-04 | 166 | 49 | 3 | 8e2faca6a2e76a625de04d6098aa6f98911945c6 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.02e-04 | 166 | 49 | 3 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.16e-04 | 167 | 49 | 3 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.16e-04 | 167 | 49 | 3 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | mild-Lymphocytic-B_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.16e-04 | 167 | 49 | 3 | 0811f7559c2a7151693771e52e14af3978997118 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 8.31e-04 | 168 | 49 | 3 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 8.31e-04 | 168 | 49 | 3 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.45e-04 | 169 | 49 | 3 | e3410ccb3f85811c75694e286115803911169a2f | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-04 | 169 | 49 | 3 | befb9b1618ea30fbf8983bcc493853da53b809c3 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass | 8.45e-04 | 169 | 49 | 3 | dba8f5599aa21feef5b7fdfed2e3ab54748d80f7 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.45e-04 | 169 | 49 | 3 | a4f610d07c3ba5537f4497f523669b914f7eddc1 | |
| Disease | Bardet-Biedl syndrome (implicated_via_orthology) | 1.35e-04 | 11 | 47 | 2 | DOID:1935 (implicated_via_orthology) | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 3.33e-04 | 17 | 47 | 2 | C2936862 | |
| Disease | Bardet-Biedl syndrome | 3.74e-04 | 18 | 47 | 2 | cv:C0752166 | |
| Disease | Ciliopathies | 7.25e-04 | 110 | 47 | 3 | C4277690 | |
| Disease | posterior urethral valve | 9.81e-04 | 29 | 47 | 2 | MONDO_0019640 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NQKDWEISHNLGVCY | 131 | Q96RK4 | |
| QLNFIAPDKHEYCIW | 651 | Q92556 | |
| WNIHGKESCDVQLYI | 26 | Q7Z6A9 | |
| CEIAWHNKEPVYSLD | 6 | Q13112 | |
| PYEHKNTWSAQNCKN | 106 | Q7L4S7 | |
| LNNPHNLTCWQSENY | 111 | O95631 | |
| ACDFLTEWLYNQNPK | 166 | Q8N0W5 | |
| QYWQHHPEKLIFQSC | 1046 | Q7Z6G8 | |
| LNLEDPNVCSHWESY | 26 | Q96KG7 | |
| FHKQQEAPDLFQWLC | 121 | Q96HD1 | |
| AKAQLLQCQHHPAWY | 1601 | Q14667 | |
| LNYVKEELHQLQCEW | 3251 | Q9NU22 | |
| KPHPQEEYLDCLWAQ | 221 | Q09161 | |
| EPQNYLAHTWVADDK | 196 | Q96MR6 | |
| CLSQDWKLFLEQHYP | 126 | Q5H9U9 | |
| KLNQENEHIYNLWCS | 196 | Q96A33 | |
| GNHLYKWKQIPDCEN | 271 | P17181 | |
| HPNNTALWQKYLLFC | 411 | Q9H7Z3 | |
| VNNWRDDQYLDDCKP | 1511 | Q93074 | |
| PCSLSVENEKYAQHW | 616 | P98088 | |
| CITIQNAYEKQHPWL | 126 | Q86Y01 | |
| QKYPNAELAWCQEEH | 946 | Q02218 | |
| AELAWCQEEHKNQGY | 951 | Q02218 | |
| ISSDCNHLLWNYKLN | 151 | Q92896 | |
| AWNAPTDQCLIKYNL | 51 | Q2M3T9 | |
| GCAQLKPNNYLLAWH | 106 | Q8NDY3 | |
| EESYCKQWLNANPSR | 711 | P32019 | |
| LQEQWNCLEHGYPEL | 571 | Q5T7N3 | |
| CISKNEWIQFNHPYT | 301 | Q9Y2U9 | |
| SNEANSKWLDAHYDP | 16 | Q8NFJ9 | |
| DLKNEVWYQKCHDPV | 436 | Q96LW4 | |
| NDLNPESHKWLLYNC | 326 | Q32P41 | |
| QNLLQHKNDENCSWP | 406 | Q9BXR5 | |
| LPDCAWQDYLDHKRQ | 821 | Q6T4R5 | |
| CTKEDYQTWHLLNQG | 696 | Q9UPU3 | |
| AGHEEYLNTWKNRCE | 396 | A6NCM1 | |
| VQKIYPFHDNWNTAC | 21 | P0DKX4 | |
| DHCLNKEVWQESGVY | 471 | O60287 | |
| NAHCVDYETQNPKWA | 476 | A6NIR3 | |
| PDILCLQEVQEDHYW | 291 | Q9UNK9 | |
| SLTDKECDWLNNYHL | 576 | Q9NQW7 | |
| EEWEHLEPAQKNLYQ | 16 | Q14586 | |
| WKQDVEGAVYHLANC | 21 | Q9HBU9 | |
| KANDICLYDDPTIHW | 111 | Q68DE3 | |
| HNQDPKDWPAQYCEA | 271 | Q96MG7 | |
| QPNKENWCQDHLYNS | 1151 | Q9ULL1 | |
| AWKEGPYCQKHELNT | 156 | Q8IWV8 | |
| KPYCNEIHAQAQLWL | 4046 | Q5T4S7 | |
| NNKDNPEIWCHYLRL | 1396 | O60293 | |
| KWIQEHPECAYNLVN | 226 | P35573 | |
| YKNYLHQWTCLPDQN | 2381 | P20929 | |
| NYLHQWTCLPDQSDV | 2626 | P20929 | |
| DYKNYLHQWTCLPDQ | 2866 | P20929 | |
| KNYLHEWTCLPDQND | 3111 | P20929 |